TREE NEWS update: Biogen reported third-quarter adjusted earnings per share of $2.62, down 45% from a year earlier but above the $2.06 market estimate. Revenue rose 11% to $2.80 billion, topping the $2.64 billion consensus, while adjusted net income fell 45% to $391.4 million, still ahead of the $300 million expected. The company guided full-year adjusted EPS to $12.20-$13.00, versus its prior $12.00-$13.00 range and the $12.38 consensus.
Biogen Q3 adjusted EPS $2.62, down 45% YoY, beating $2.06 estimate
AI take
The headline drop masks a cleaner story: revenue growth of 11% and beats on both top and bottom lines suggest the core business is holding up better than the year-over-year EPS comparison implies. The narrowed and slightly raised full-year EPS guide signals management has more visibility into the back half, which matters for a name where sentiment has been fragile. Whether that revenue momentum persists as the year closes is the open question, and the guidance range's width leaves room for either outcome.
Generated by AI for reference only.
Share on WeChat
Open WeChat → Scan → then tap "…" to send to a chat or Moments.
Tap "…" in the top-right corner to send to a chat or share to Moments.
Related News
13m ago
UMC Q3 operating profit NT$18.64B, beating NT$18.41B estimate
29m ago
Fannie Mae Q3 net income $7.65B, beats $7.22B estimate
1h ago
Wells Fargo cuts Robinhood price target to $100 from $120
1h ago
China Mutual Funds’ Q3 Top Holdings: Zhongji Innolight Leads, CXMT Enters
1h ago
Yibo Technology Unit to Invest 1B Yuan in AI Computing PCB Plant
1h ago
GE Vernova to acquire Trench Group for $9 billion